Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Antonio Bencomo Hernandez"'
Autor:
Gisela María Suárez, Mauricio Catalá, Yadira Peña, Susana Portela, Ana Laura Añé-Kourí, Amnely González, Patricia Lorenzo-Luaces, Manuel Díaz, María de los A. Molina, Karla Pereira, Jenysbel de la C. Hernández, Mary Carmen Reyes, Nuris Ledón, Zaima Mazorra, Tania Crombet, Agustin Lage, Antonio Bencomo-Hernandez, Danay Saavedra
Publikováno v:
Exploration of Immunology, Vol 4, Iss 4, Pp 433-445 (2024)
Aim: Currently, malignant diseases represent a health issue worldwide. Among these, lung cancer is of growing importance, due to its high incidence and mortality. Chemotherapy, one of the most frequently used treatments, has shown its ability to indu
Externí odkaz:
https://doaj.org/article/0b6fbfbd307b4617a1722a3f7ca859ec
Autor:
Ottorino Del Foco, Antonio Bencomo-Hernandez, Yandy Castillo-Aleman, Pierdanilo Sanna, Stefano Benedetti, Enrico Dassen
Publikováno v:
Journal of Diabetes and Endocrine Practice. :154-159
Critical limb ischemia (CLI) is considered the end-stage of peripheral arterial disease, with a prevalence between 2% and 4% in the general population and more than 15% in older adults. One-year major amputation rate can reach 30%, and diabetic patie
Autor:
Gina Marcela Torres Zambrano, Rene Antonio Rivero, Antonio Bencomo Hernandez, Carlos Alfonso Villegas Valverde, Yendry Ventura Carmenate, Lobna Abdel Hadi
BackgroundThe COVID-19 pandemic presented an unprecedented challenge to identify effective drugs for prevention and treatment.ObjectiveTo characterize acute renal injury (AKI) in patients with COVID-19 and their relation with clinical outcomes within
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f200eb630e0579e11efa6cd17b57224
https://doi.org/10.1101/2020.12.16.20236877
https://doi.org/10.1101/2020.12.16.20236877
Publikováno v:
Immunotherapy Weekly; 9/17/2024, p149-149, 1p